[Routine diagnosis of coli enteritis, H antigen analysis and immunofluorescence. 2. Therapy and resistance].
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D000941:Antigens / Q000032:analysis*; D002701:Chloramphenicol / Q000494:pharmacology; D003523:Cycloserine / Q000494:pharmacology; D003864:Depression, Chemical; D004352:Drug Resistance, Microbial; D004415:Dyspepsia / Q000188:drug therapy; D004751:Enteritis / Q000175:diagnosis / Q000188:drug therapy*; D004926:Escherichia coli / Q000187:drug effects / Q000276:immunology*; D004927:Escherichia coli Infections / Q000175:diagnosis / Q000188:drug therapy*; D005243:Feces / Q000382:microbiology; D005455:Fluorescent Antibody Technique; D006801:Humans; D007223:Infant; D008722:Methods; D009355:Neomycin / Q000494:pharmacology; D009581:Nitrofurans / Q000494:pharmacology; D013307:Streptomycin / Q000494:pharmacology
D000900:Anti-Bacterial Agents; D000941:Antigens; D009581:Nitrofurans; D002701:Chloramphenicol; D003523:Cycloserine; D009355:Neomycin; D013307:Streptomycin
Routinediagnostik der Enteritiscoli, H-Antigen-Analyse und Immunfluorescenz. 2. Sanierung und Resistenz.